Episode 61
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
Episode 61
-
Narrado por:
-
De:
Acerca de esta escucha
In this episode Dr. Stader and Dr. Bradley summarize and offer key insights for the following Coaches Top 5 picks discussing Journavx (suzetrigine), recommendations for vitamin D and calcium supplementation, perioperative use of tapentadol, and more!
-
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain, Published as an FDA News Release, January 2025
-
Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Falls and Fractures in Community-Dwelling Adults: Preventive Medication, Published by the U.S. Preventive Services Task Force, December 2024
-
Considerations for perioperative opioid analgesic stewardship in Australia: a focus on tapentadol, Published in Pain Management, June 2023
-
The Overdose Crisis among U.S. Adolescents, Published in the New England Journal of Medicine, January 2024
-
Mortality Trends Among Early Adults in the United States, 1999-2023, Published in JAMA Network Open, January 2025